Solmaz Fakhari - Associate Professor, Department of Anesthesiology, Tabriz University of Medical Sciences, Tabriz, Iran
Hojjat Pourfathi - Associate Professor, Department of Anesthesiology, Tabriz University of Medical Sciences, Tabriz, Iran
Haleh Farzin - Assistant of Anesthesiology, Department of Anesthesiology, Tabriz University of Medical Sciences, Tabriz, Iran
Eisa Bilehjani - Associate Professor, Department of Anesthesiology, Tabriz University of Medical Sciences, Tabriz, Iran

Breast cancer is a common type of cancer among female human populations. Approximately, one million new cases are diagnosed per year and it is expected that this amount will increase in the future. In recent years, the common standard surgical procedures for the treatment of breast invasive carcinoma are breast-protective surgery and modified radical mastectomy. Residual tumor after surgery, stage T3–T4, metastases to 4 axillary lymph nodes or greater, and extracapsular axillary lymph node disease that is treated with adjuvant chemotherapy are indications of surgery. Post-mastectomy radiotherapy results in an increased disease-free condition and survival rate. With the improvement of survival rate, the procedure has been focused on quality of breast cancer survivors.

Post Mastectomy, Pain, Phantom